Skip to main content

Animations

MJFF Publications

1761 - 1770 of 6431 Results
Title
Year
  • Year
  • 2018
  • 2018
  • 2016
  • 2016
  • 2015
  • 2015
  • 2014
  • 2014
  • 2014
  • 2014
  • Summary Details
    OPEN
    Title: Uncovering the heterogeneity and temporal complexity of neurodegenerative diseases with Subtype and Stage Inference
    Journal Name: Nature Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41467-018-05892-0
    Citation Count: 434
  • Summary Details
    OPEN
    Title: TMEM106B haplotypes have distinct gene expression patterns in aged brain
    Journal Name: Molecular Neurodegeneration
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s13024-018-0268-2
    Citation Count: 37
  • Summary Details
    OPEN
    Title: Bifunctional Anti-Non-Amyloid Component α-Synuclein Nanobodies Are Protective In Situ
    Journal Name: PLOS ONE
    Publisher: Public Library of Science (PLoS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1371/journal.pone.0165964
    Citation Count: 63
  • Summary Details
    OPEN
    Title: Progression of Regional Microstructural Degeneration in Parkinson’s Disease: A Multicenter Diffusion Tensor Imaging Study
    Journal Name: PLOS ONE
    Publisher: Public Library of Science (PLoS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1371/journal.pone.0165540
    Citation Count: 89
  • Summary Details
    OPEN
    Title: Blood Biomarkers Associated with Cognitive Decline in Early Stage and Drug-Naive Parkinson’s Disease Patients
    Journal Name: PLOS ONE
    Publisher: Public Library of Science (PLoS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1371/journal.pone.0142582
    Citation Count: 52
  • Summary Details
    OPEN
    Title: Glitazone Treatment and Incidence of Parkinson’s Disease among People with Diabetes: A Retrospective Cohort Study
    Journal Name: PLOS Medicine
    Publisher: Public Library of Science (PLoS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1371/journal.pmed.1001854
    Citation Count: 122
  • Summary Details
    OPEN
    Title: The hTH-GFP Reporter Rat Model for the Study of Parkinson's Disease
    Journal Name: PLoS ONE
    Publisher: Public Library of Science (PLoS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1371/journal.pone.0113151
    Citation Count: 20
  • Summary Details
    OPEN
    Title: Phosphorylation by PINK1 Releases the UBL Domain and Initializes the Conformational Opening of the E3 Ubiquitin Ligase Parkin
    Journal Name: PLoS Computational Biology
    Publisher: Public Library of Science (PLoS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1371/journal.pcbi.1003935
    Citation Count: 109
  • Summary Details
    OPEN
    Title: LRRK2 Transport Is Regulated by Its Novel Interacting Partner Rab32
    Journal Name: PLoS ONE
    Publisher: Public Library of Science (PLoS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1371/journal.pone.0111632
    Citation Count: 94
  • Summary Details
    OPEN
    Title: Dopaminergic Neurotoxicants Cause Biphasic Inhibition of Purinergic Calcium Signaling in Astrocytes
    Journal Name: PLoS ONE
    Publisher: Public Library of Science (PLoS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1371/journal.pone.0110996
    Citation Count: 13
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.